Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
The clinical drug candidate ebselen attenuates inflammati... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
The clinical drug candidate ebselen attenuates inflammation and promotes microbiome recovery after antibiotic treatment for Clostridium difficile infection
0
Authors
Megan Garland
7 more
Megan Garland
•
Andrew Hryckowian
5 more
•
Matthew Bogyo
Published
November 1, 2019
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Bioinformatics
Medicine
Immunology
Microbiology
Show all topics
DOI
10.1101/827329
License
CC-BY-NC-ND
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Bioinformatics
Medicine
Immunology
Microbiology
Show all topics
DOI
10.1101/827329
License
CC-BY-NC-ND
Other Formats
PDF
